Technical Analysis for ATNX - Athenex, Inc.

Grade Last Price % Change Price Change
grade C 14.55 -14.21% -2.41
ATNX closed down 14.21 percent on Friday, December 13, 2019, on 5.56 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
See historical ATNX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
New Downtrend Bearish 0.00%
200 DMA Support Bullish 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Slingshot Bullish Bullish Swing Setup -14.21%
Older signals for ATNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel, and an oral formulation of Topotecan for the treatment of various types of cancers. Its Src Kinase Inhibitors include KX-01 (KX2-391) and KX-02 (KX2-361) oncology drug candidates. The Company's Symptom Therapeutics include CQ-01, which is used for the treatment of burn pruritus and scars; CQ-R1, which is used for the treatment of an irradiation-induced dermatitis, and an intranasal Granisetron used for the treatment of chemotherapy-induced nausea/vomiting.
Chemistry Organic Compounds Oncology Cancers Chemotherapy Organic Chemistry Antineoplastic Drugs Therapies For Cancer Pruritus Scars Docetaxel Treatment Of Various Types Of Cancers

Is ATNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.11
52 Week Low 8.82
Average Volume 1,254,864
200-Day Moving Average 14.25
50-Day Moving Average 13.00
20-Day Moving Average 15.69
10-Day Moving Average 16.50
Average True Range 1.17
ADX 46.62
+DI 24.97
-DI 28.27
Chandelier Exit (Long, 3 ATRs ) 14.84
Chandelier Exit (Short, 3 ATRs ) 14.60
Upper Bollinger Band 18.88
Lower Bollinger Band 12.51
Percent B (%b) 0.32
BandWidth 40.59
MACD Line 1.01
MACD Signal Line 1.16
MACD Histogram -0.1412
Fundamentals Value
Market Cap 830.27 Million
Num Shares 57.1 Million
EPS -3.47
Price-to-Earnings (P/E) Ratio -4.19
Price-to-Sales 47.88
Price-to-Book 7.97
PEG Ratio 0.98
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.56
Resistance 3 (R3) 20.83 19.10 19.56
Resistance 2 (R2) 19.10 17.57 18.96 19.22
Resistance 1 (R1) 16.82 16.62 15.96 16.55 18.89
Pivot Point 15.09 15.09 14.66 14.96 15.09
Support 1 (S1) 12.82 13.56 11.95 12.55 10.21
Support 2 (S2) 11.09 12.62 10.95 9.88
Support 3 (S3) 8.81 11.09 9.54
Support 4 (S4) 8.54